P. W. Wijermans

2.1k citations

49 papers · 1.6k indexed · h-index 18

Co-authors: H. L. Haak W.B.J. Gerrits Frits R. Rosendaal Hanneke C. Kluin‐Nelemans Henk J. Blom Martin den Heijer Gerard M.J. Bos Paul Neve
Topics: Lymphoma Diagnosis and Treatment (12 papers)Acute Myeloid Leukemia Research (11 papers)Multiple Myeloma Research and Treatments (10 papers)
Cited by: Hematology Genetics Internal Medicine
Journals: The Lancet Blood Journal of Clinical Epidemiology
Partner nations: Netherlands Belgium Germany

In The Last Decade

P. W. Wijermans

49 papers receiving 1.5k citations

Peers

Countries citing papers authored by P. W. Wijermans

Since Specialization

Citations

This map shows the geographic impact of P. W. Wijermans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. W. Wijermans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. W. Wijermans more than expected).

Fields of papers citing papers by P. W. Wijermans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. W. Wijermans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. W. Wijermans. The network helps show where P. W. Wijermans may publish in the future.

Co-authorship network of co-authors of P. W. Wijermans

This figure shows the co-authorship network connecting the top 25 collaborators of P. W. Wijermans. A scholar is included among the top collaborators of P. W. Wijermans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. W. Wijermans. P. W. Wijermans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Factors that influence treatment decision-making in elderly DLBCL patients: a case vignette study 2015 ·Annals of Hematology ·Marjolein van der Poel,Wubbo J. Mulder,G.J. Ossenkoppele,E. Maartense,Mels Hoogendoorn,P. W. Wijermans,H.C. Schouten	11
2	Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome 2012 ·Haematologica ·Barbara Deschler-Baier,Gabriele Ihorst,(unknown),Ulrich Germing,(unknown),(unknown),Kurt Fritzsche,Peter Haas,Helmut R. Salih,Aristoteles Giagounidis,Dominik Selleslag,Boris Labar,T. de Witte,P. W. Wijermans,Michael Lübbert	152
3	Regression of HIV-associated grade IV T cell lymphoma with combined antiretroviral therapy only 2011 ·International Journal of Hematology ·Y K Onno Teng,Emile F. Schippers,P. W. Wijermans	1
4	Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial 2010 ·Haematologica ·T. de Witte,A Hagemeijer,Stefan Suciu,Amine Belhabri,Michel Delforge,Guido Kobbe,(unknown),Harry C. Schouten,Augustin Ferrant,Harald Biersack,Sergio Amadori,Petra Muus,Joop H. Jansen,Eva Hellström‐Lindberg,Tibor Kovacsovics,P. W. Wijermans,GJ Ossenkoppele,Aloïs Gratwohl,J. P. Marie,(unknown)	52
5	Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma 2005 ·Leukemia ·Gustaaf W. van Imhoff,Bronno van der Holt,Marius MacKenzie,G.J. Ossenkoppele,P. W. Wijermans,Mark H.H. Kramer,Mars B. van ’t Veer,Harry C. Schouten,Marinus van Marwijk Kooy,Marinus H. J. van Oers,John Raemaekers,Pieter Sonneveld,(unknown),P.M. Kluin,Hanneke C. Kluin‐Nelemans,Leo F. Verdonck	30
6	Splenectomy for the treatment of thrombotic thrombocytopenic purpura 2005 ·British Journal of Haematology ·M. C. Kappers‐Klunne,P. W. Wijermans,Rob Fijnheer,Alexandra Croockewit,Bronno van der Holt,J. Th. M. de Wolf,Bob Löwenberg,Anneke Brand	83
7	Exclusion of venous thromboembolism: evaluation of D-Dimer PLUS for the quantitative determination of D-dimer 2004 ·Thrombosis Research ·Henricus J. Vermeer,Paula F. Ypma,Marco J. L. van Strijen,(unknown),(unknown),(unknown),P. W. Wijermans,W.B.J. Gerrits	15
8	Acute myeloid leukemia of the elderly: results of induction after previous treatment of high-risk myelodysplastic syndrome with a demethylating agent 2003 ·FreiDok plus (Universitätsbibliothek Freiburg) ·Michael Lübbert,P. W. Wijermans,Thomas Licht,(unknown)	1
9	The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921) 2003 ·Leukemia ·(unknown),Stefan Suciu,G. Verhoef,Boris Labar,Amine Belhabri,Carlo Aul,Dominik Selleslag,Augustin Ferrant,P. W. Wijermans,Franco Mandelli,Sergio Amadori,U. Jehn,Petra Muus,R Zittoun,U Hess,Özlem Anak,F Beeldens,Roel Willemze,T de Witte	31
10	Age-related differences among patients with follicular lymphoma and the importance of prognostic scoring systems: analysis from a population-based non-Hodgkin’slymphoma registry 2002 ·Annals of Oncology ·E. Maartense,Saskia le Cessie,Hanneke C. Kluin‐Nelemans,P. M. Kluin,Simone Snijder,P. W. Wijermans,Evert M. Noordijk	21
11	Disappearance of a mucosa‐associated lymphoid tissue (MALT) lymphoma of the urinary bladder after treatment for Helicobacter pylori 2002 ·European Journal Of Haematology ·(unknown),(unknown),P Blok,P. W. Wijermans	27
12	Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factors 2002 ·Leukemia ·(unknown),Petra Muus,Stefan Suciu,Charles Koller,G. Verhoef,Boris Labar,P. W. Wijermans,C. Aul,D Fière,Dominik Selleslag,R. Willemze,Aloïs Gratwohl,Augustin Ferrant,Franco Mandelli,Jörge E. Cortes,T. de Witte,Elihu H. Estey	45
13	A randomized study of granulocyte colony-stimulating factor applied during and after chemotherapy in patients with poor risk myelodysplastic syndromes: a report from the HOVON Cooperative Group 1999 ·Leukemia ·GJ Ossenkoppele,Bronno van der Holt,(unknown),(unknown),LF Verdonck,Pieter Sonneveld,P. W. Wijermans,J. van der Lelie,WLJ van Putten,Bob Löwenberg,(unknown)	20
14	A randomized study of granulocyte-colony stimulating factor applied during and after chemotherapy in patients, with poor risk myelodysplastic syndromes: A final report from the Hovon Cooperative Group. 1998 ·Data Archiving and Networked Services (DANS) ·GJ Ossenkoppele,Bronno van der Holt,(unknown),(unknown),LF Verdonck,Pieter Sonneveld,P. W. Wijermans,J. van der Lelie,WLJ van Putten,Bob Löwenberg	1
15	Elderly patients with non-Hodgkin’s lymphoma: Population-based results in the Netherlands 1998 ·Annals of Oncology ·E. Maartense,J. Hermans,Hanneke C. Kluin‐Nelemans,P.M. Kluin,(unknown),Simone Snijder,P. W. Wijermans,E.M. Noordijk	45
16	Developing a population-based registry for patients with paraproteinemias or multiple myeloma 1997 ·Journal of Clinical Epidemiology ·F. Ong,J. Hermans,E.M. Noordijk,(unknown),P. W. Wijermans,(unknown),Simone Snijder,(unknown),Hanneke C. Kluin‐Nelemans	7
17	A population‐based registry on paraproteinaemia in the Netherlands 1997 ·British Journal of Haematology ·F. Ong,J. Hermans,E.M. Noordijk,P. W. Wijermans,(unknown),(unknown),(unknown),(unknown),Hanneke C. Kluin‐Nelemans	27
18	Continuous infusion of low-dose 5-Aza-2′-deoxycytidine in elderly patients with high-risk myelodysplastic syndrome 1997 ·Leukemia ·P. W. Wijermans,(unknown),(unknown),Paul Neve	156
19	Systemic Fusarium nygamai infection in a patient with lymphoblastic non‐Hodgkin's lymphoma 1996 ·Mycoses ·(unknown),R.W. Brimicombe,P. W. Wijermans,W. Gams	8
20	Hyaline-Vascular Type Castleman’s Disease with Concomitant Malignant B-Cell Lymphoma 1992 ·Acta Haematologica ·(unknown),P. W. Wijermans,K. van Groningen,(unknown),Ph. M. Kluin,H. L. Haak	9

About P. W. Wijermans

P. W. Wijermans is a scholar working on Hematology, Genetics and Oncology, having authored 49 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (12 papers), Acute Myeloid Leukemia Research (11 papers) and Multiple Myeloma Research and Treatments (10 papers). The work is most often cited by research in Hematology (792 citations), Genetics (304 citations) and Internal Medicine (90 citations). P. W. Wijermans has collaborated with scholars based in Netherlands, Belgium and Germany. Frequent co-authors include H. L. Haak, W.B.J. Gerrits, Frits R. Rosendaal, Hanneke C. Kluin‐Nelemans, Henk J. Blom, Martin den Heijer, Gerard M.J. Bos, Paul Neve, J. Hermans and E.M. Noordijk. Their work appears in journals such as The Lancet, Blood and Journal of Clinical Epidemiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact